Shares of Tesaro (TSRO) jumped in late day trading after Bloomberg said the company is working with advisers to explore a possible sale after receiving takeover interest.
Following the report, Tesaro shares rose $2.58, or 9.7%, to $29.17. Clovis Oncology (CLVS), which markets Rubraca, a competitor to Tesaro’s Zejula, gained 9% following the report as well.
